- Tome Skincare featured in Cosmopolitan, Women's Wear Daily, AIR MAIL, and Thingtesting highlights Tome's growing recognition among leading beauty editors -
SAN DIEGO, CA / ACCESS Newswire / November 5,
- Tome Clearing Treatment is Dermata's second once-weekly skincare product under its Tome brand -- Tome Clearing Treatment includes a salicylic acid wipe with Dermata's Bioneedle™ mask and is expected to launch
- Once-weekly Tome Foundational Treatment demonstrated improvements across key measures of skin appearance after four treatments -- Over 71% of study participants were graded as having overall improvements in their skin
- Tome Foundational Treatment, powered by Bioneedle™, is now available for purchase at www.tomeskincare.com -- Once-weekly Foundational Treatment is designed to renew the appearance of skin and improve tone and texture
- Preorders can be made by visiting www.tomeskincare.com -- Dermata is ready to begin shipping orders on the expected launch date of August 25, 2026 -- Tome Foundational Treatment is a once-weekly topical mask for skin
$3.4 million upfront with up to approximately $6.7 million of potential additional gross proceeds upon the exercise in full of warrants SAN DIEGO, CA / ACCESS Newswire / August 17, 2026 / Dermata Therapeutics, Inc.
- Dermata announced the launch date of its first commercial product, Tome™ Foundational Treatment, expected on August 25, 2026 -- Dermata recently attended Be+Well Beauty and Wellness Show in Las Vegas, NV to announce
- A new chapter in skincare has arrived -- This will be Dermata's first commercial product launch, planned for August 25, 2026 -- Join the waitlist at tomeskincare.com - SAN DIEGO, CA / ACCESS Newswire / August 5,
- Dermata announced their Tome Skincare brand for direct-to-consumer ("DTC") skincare products -- Dermata plans to launch its first DTC product, the Tome Foundational Treatment, a once-weekly mask to support skin
- This would be Dermata's first patent, if issued, covering the use of its Bioneedle Delivery System ("BDS") with dermal fillers -- The Company also has allowed and issued patents in the US, Australia, and Japan covering
- Dermata announced a strategic pivot to develop and commercialize direct-to-consumer ("DTC") skincare products under the brand name Tome -- Dermata plans to launch its first DTC product, our Foundational Treatment, a
- Kyra Peckaitis will lead the launch of Dermata's recently announced Tome skincare brand -SAN DIEGO, CA / ACCESS Newswire / March 10, 2026 / Dermata Therapeutics, Inc. ("Dermata," or the "Company")
-The oldest new thing in skincare -- Dermata expects to launch its first product in the middle of 2026 -SAN DIEGO, CA / ACCESS Newswire / March 5, 2026 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata"
This patent grant follows the Company's U.S. issued patent, covering its Spongilla technology combination as a method to topically treat acneDermata expects to launch a new once-weekly, over-the-counter (OTC) acne
$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon the exercise in full of warrantsSAN DIEGO, CA / ACCESS Newswire / December 29, 2025 / Dermata Therapeutics, Inc.
